ACIU
NASDAQ · Biotechnology
Ac Immune Sa
$2.92
+0.06 (+2.10%)
Open$2.97
Previous Close$2.86
Day High$3.08
Day Low$2.88
52W High$29.08
52W Low$11.97
Volume—
Avg Volume783.5K
Market Cap310.68M
P/E Ratio—
EPS$0.04
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+714.4% upside
Current
$2.92
$2.92
Target
$23.78
$23.78
$21.93
$23.78 avg
$37.21
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 116.52M | 119.79M | 119.57M |
| Net Income | 209.8K | 199.8K | 200.3K |
| Profit Margin | 0.2% | 0.2% | 0.2% |
| EBITDA | 267.6K | 316.5K | 305.4K |
| Free Cash Flow | 236.0K | 248.3K | 178.6K |
| Rev Growth | +18.7% | -0.9% | +8.9% |
| Debt/Equity | 0.72 | 0.69 | 0.73 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |